BiomX (NYSEAMERICAN:PHGE – Get Free Report) is anticipated to announce its earnings results before the market opens on Tuesday, March 25th. Analysts expect the company to announce earnings of ($1.10) per share for the quarter.
BiomX Stock Up 1.9 %
Shares of NYSEAMERICAN PHGE opened at $0.64 on Friday. BiomX has a 52 week low of $0.48 and a 52 week high of $4.99. The stock has a market capitalization of $11.67 million, a price-to-earnings ratio of -0.20 and a beta of 1.27.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reaffirmed a “buy” rating and issued a $2.00 price target on shares of BiomX in a research note on Wednesday, January 8th.
About BiomX
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
See Also
- Five stocks we like better than BiomX
- Golden Cross Stocks: Pattern, Examples and Charts
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
- The How And Why of Investing in Oil Stocks
- Alphabet Stock Becomes a Low-Risk, High-Reward Play
- What Is WallStreetBets and What Stocks Are They Targeting?
- Affirm Stock: Should You Buy the Dip After Walmart Setback?
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
